Term ends Mar 20, 2037 · High confidence
20-year base term ends Feb 3, 2036
Held by Seven Bridges Genomics Inc.
Filed Feb 3, 2016 as application 15/014,500 · Granted Jul 28, 2020
Base term plus 468 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2016
2037
Clock starts
Feb 3, 2016
Feb 3, 2016
Term ends
Mar 20, 2037
Mar 20, 2037
Granted
Jul 28, 2020
Jul 28, 2020
base term
patent term adjustment
fee events
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
468
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,584,380, US 10,793,895.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 468 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 3, 2016, when this application, 15/014,500, was filed | Feb 3, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +468 days, USPTO patent term adjustment record | May 16, 2037 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,584,380, US 10,793,895) | capped to Mar 20, 2037 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 20, 2037 | High confidence |
This family
| US 10,724,110 | this patent Mar 2037 | Mar 2037 |
| US 11,702,708 | In force no later than Nov 2036 | no later than Nov 2036 |
| US 12,173,374 | In force Feb 2036 | Feb 2036 |
| Application 18/947,751 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 5, 2016 Reel 37672, frame 265 | Locke, Devin; Szamel, Piotr | Seven Bridges Genomics Inc. | Assignment of Assignor's Interest |
| Jun 15, 2016 Reel 39038, frame 535 | Seven Bridges Genomics Inc. | Venture Lending & Leasing VII, Inc. | Security Interest |
| Oct 10, 2017 Reel 44174, frame 50 | Venture Lending & Leasing VII, Inc. | Seven Bridges Genomics Inc.; Seven Bridges Genomics UK Ltd.; Seven Bridges Genomics D.O.O. | Termination and Release of Security Interest in Patents |
| Oct 10, 2017 reel/frame not recorded | Venture Lending & Leasing VII, Inc. | Seven Bridges Genomics Inc. | Termination and Release of Security Interest in Patents |
| Oct 10, 2017 reel/frame not recorded | Venture Lending & Leasing VII, Inc. | Seven Bridges Genomics UK Ltd. | Termination and Release of Security Interest in Patents |
| Oct 10, 2017 reel/frame not recorded | Venture Lending & Leasing VII, Inc. | Seven Bridges Genomics D.O.O. | Termination and Release of Security Interest in Patents |
| Oct 11, 2017 Reel 44174, frame 113 | Seven Bridges Genomics Inc. | Brown Rudnick | Notice of Attorney's Lien |
| Oct 17, 2017 Reel 44305, frame 871 | Seven Bridges Genomics Inc. | Mjolk Holding B.V. | Security Interest |
| Apr 12, 2018 Reel 45928, frame 13 | Mjolk Holding B.V. | Seven Bridges Genomics Inc. | Release of Security Interest |
| Sep 13, 2018 Reel 46943, frame 683 | Brown Rudnick LLP | Seven Bridges Genomics Inc. | Termination and Release of Notice of Attorney's Lien |
| Mar 30, 2022 Reel 59554, frame 165 | Seven Bridges Genomics Inc. | Imperial Financial Services B.V. | Security Interest |
| May 24, 2022 Reel 60173, frame 792 | Imperial Financial Services B.V. | Seven Bridges Genomics Inc. | Release of Security Interest |
| May 24, 2022 Reel 60173, frame 803 | Seven Bridges Genomics Inc. | Imperial Financial Services B.V. | Security Interest |
| Aug 2, 2022 Reel 61055, frame 78 | Imperial Financial Services B.V. | Seven Bridges Genomics Inc. | Release of Security Interest |
| Aug 4, 2022 Reel 61084, frame 786 | Pieriandx, Inc.; Seven Bridges Genomics Inc. | Orbimed Royalty & Credit Opportunities III, LP | Security Interest |
| Oct 9, 2026 reel/frame not recorded | Orbimed Royalty & Credit Opportunities III, LP | Pieriandx, Inc. | Release of Security Interest |
| Oct 9, 2026 reel/frame not recorded | Orbimed Royalty & Credit Opportunities III, LP | Seven Bridges Genomics Inc. | Release of Security Interest |
| Oct 9, 2026 Reel 76676, frame 119 | Orbimed Royalty & Credit Opportunities III, LP | Pieriandx, Inc.; Seven Bridges Genomics Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2037
Term ends Mar 20, 2037. Maintenance fees still fall due before then
Note
The 468 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,584,380, US 10,793,895.
Citations
51
later US patents cite this one
That is top 5% of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.